Lite Strategy, Inc. (LITS)
1.12
+0.08
(+7.69%)
USD |
NASDAQ |
Sep 18, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Lite Strategy Total Return Level : 1.336 for Sept. 17, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 17, 2026 | 1.336 |
| September 16, 2026 | 1.311 |
| September 15, 2026 | 1.401 |
| September 14, 2026 | 1.478 |
| September 11, 2026 | 1.426 |
| September 10, 2026 | 1.362 |
| September 09, 2026 | 1.362 |
| September 08, 2026 | 1.414 |
| September 04, 2026 | 1.465 |
| September 03, 2026 | 1.336 |
| September 02, 2026 | 1.336 |
| September 01, 2026 | 1.277 |
| August 31, 2026 | 1.266 |
| August 28, 2026 | 1.260 |
| August 27, 2026 | 1.285 |
| August 26, 2026 | 1.276 |
| August 25, 2026 | 1.349 |
| August 24, 2026 | 1.324 |
| August 21, 2026 | 1.272 |
| August 20, 2026 | 1.212 |
| August 19, 2026 | 1.208 |
| August 18, 2026 | 1.133 |
| August 17, 2026 | 1.131 |
| August 14, 2026 | 1.139 |
| August 13, 2026 | 1.151 |
| Date | Value |
|---|---|
| August 12, 2026 | 1.184 |
| August 11, 2026 | 1.158 |
| August 10, 2026 | 1.118 |
| August 07, 2026 | 1.166 |
| August 06, 2026 | 1.194 |
| August 05, 2026 | 1.228 |
| August 04, 2026 | 1.213 |
| August 03, 2026 | 1.261 |
| July 31, 2026 | 1.238 |
| July 30, 2026 | 1.269 |
| July 29, 2026 | 1.222 |
| July 28, 2026 | 1.246 |
| July 27, 2026 | 1.255 |
| July 24, 2026 | 1.270 |
| July 23, 2026 | 1.274 |
| July 22, 2026 | 1.324 |
| July 21, 2026 | 1.285 |
| July 20, 2026 | 1.324 |
| July 17, 2026 | 1.268 |
| July 16, 2026 | 1.247 |
| July 15, 2026 | 1.271 |
| July 14, 2026 | 1.281 |
| July 13, 2026 | 1.215 |
| July 10, 2026 | 1.298 |
| July 09, 2026 | 1.276 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| SELLAS Life Sciences Group, Inc. | 11.53 |
| ACADIA Pharmaceuticals, Inc. | 27.45 |
| Alnylam Pharmaceuticals, Inc. | 245.51 |
| Anika Therapeutics, Inc. | 21.03 |
| Savara, Inc. | 5.42 |